<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="557">
  <stage>Registered</stage>
  <submitdate>12/09/2005</submitdate>
  <approvaldate>23/09/2005</approvaldate>
  <actrnumber>ACTRN12605000490673</actrnumber>
  <trial_identification>
    <studytitle>Women's Lifestyle Study</studytitle>
    <scientifictitle>Women in action: a randomised controlled trial to evaluate the effects of a physical activity intervention on risk factors for diabetes and heart disease in 40-75yr old women</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Risk factors associated with type 2 diabetes and heart disease</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention: Baseline measures followed by physical activity advice given by telephone over 5mths, a face-to-face visit with a research nurse at 6mths and further telephone contact at 9mths. Intervention complete at 9mths, outcomes assessed at 12 and 24mths.</interventions>
    <comparator>Control: Baseline measures followed by reassessment at 12 and 24mths.</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Adherence to physical activity</outcome>
      <timepoint>At 12 and 24 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Cost-effectiveness ratios</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Blood pressure</outcome>
      <timepoint>Measured at baseline and repeated at 12 and 24 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Waist circumference</outcome>
      <timepoint>Measured at baseline and repeated at 12 and 24 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Weight</outcome>
      <timepoint>Measured at baseline and repeated at 12 and 24 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Fasting bloods including glucose</outcome>
      <timepoint>Measured at baseline and repeated at 12 and 24 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Lipids</outcome>
      <timepoint>Measured at baseline and repeated at 12 and 24 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>HBA1c and insulin</outcome>
      <timepoint>Measured at baseline and repeated at 12 and 24 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Physical fitness</outcome>
      <timepoint>Measured at baseline and repeated at 12 and 24 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Able to participate in moderate intensity physical activity.</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Blood pressure &gt;=200/110; deemed ineligible for participation in moderate intensity physical activity by GP (e.g. acutely unwell or injured).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelope containing group allocation opened by studynurse at completion of baseline measures.</concealment>
    <sequence>Computer generated by independent researcher using STATA in random blocks with variable block sizes</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>24/11/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>1080</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>National Heart Foundation of NZ</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>National Heart Foundation of NZ</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Hutt Valley District Health Board</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Lottery Health Research Grants Board</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Government body</sponsortype>
      <sponsorname>Hutt Valley District Health Board</sponsorname>
      <sponsoraddress />
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Government body</sponsortype>
      <sponsorname>Lottery Health Research Grants Board</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname> the Wellington Ethics Committee (now known as the Central Regional Ethics Committee)</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Beverley Lawton</name>
      <address>Department of Primary Health Care and General Practice
Wellington School of Medicine &amp; Health Sciences
University of Otago
PO Box 7343
Wellington</address>
      <phone>+64 4 3855995 ext. 4893</phone>
      <fax>+64 4 3855473</fax>
      <email>bevlawton@wnmeds.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Sally Rose</name>
      <address>Department of Primary Health Care and General Practice
Wellington School of Medicine &amp; Health Sciences
University of Otago
PO Box 7343
Wellington</address>
      <phone>+64 4 9186249</phone>
      <fax>+64 4 3855473</fax>
      <email>srose@wnmeds.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>